First-Line Decisions in ADHD: Lifestyle Modification or Medication? 

 ADHD in the News 2026-10-01


Should attention-deficit/hyperactivity disorder (ADHD) treatment begin with medication or lifestyle modification? Psych Congress Network sat down with meeting Co-Chair, Julie Carbray, PhD, PMHNP-BC, FAAN, and Steering Committee member James Greenblatt, MD, to discuss essential insights from their 2026 Psych Congress session, “First-Line Decisions: Lifestyle Modification or Medication? Balancing Pharmacologic and Non-Pharmacologic Care in ADHD.”

View Article: Psych Congress Network, September 18, 2026




Other Articles in this Edition

Early-Onset Type 2 Diabetes More Likely In People With ADHD, Autism 

What if A.D.H.D. Isn’t About Attention at All? 

NHS bodies in England impose two-year minimum wait for ADHD and autism assessments 

What’s Behind ADHD’s Moment on Social Media? Syracuse Psychologist Weighs In

Peer Exchange: Managing Adult ADHD: Addressing Diagnosis, Treatment Selection, and All-Day Symptom Control, EP. 5 & 6 (Opinion)

As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right

Years of fine-particle pollution track with childhood ADHD rates across US counties 

Placenta problems associated with ADHD 

FIU study finds brain differences linked to obesity risk in preschoolers 

Pediatric Psychiatric Multimorbidity May Increase Risk for Physical Conditions 

How adults feel about their ADHD depends heavily on their specific symptoms 

First-Line Decisions in ADHD: Lifestyle Modification or Medication? 

The invisible performance of ‘masking’ ADHD symptoms is exhausting